Genetic Pathogenesis of Hypertrophic and Dilated Cardiomyopathy
- PMID: 29525643
- PMCID: PMC5851453
- DOI: 10.1016/j.hfc.2017.12.004
Genetic Pathogenesis of Hypertrophic and Dilated Cardiomyopathy
Abstract
Sarcomere cardiomyopathies are genetic diseases that perturb contractile function and lead to hypertrophic or dilated myocardial remodeling. Identification of preclinical mutation carriers has yielded insights into the earliest biomechanical defects that link pathogenic variants to cardiac dysfunction. Understanding this early molecular pathophysiology can illuminate modifiable pathways to reduce the emergence of overt cardiomyopathy and curb adverse outcomes. Here, the authors review current understandings of how human hypertrophic cardiomyopathy- and hypertrophic dilated cardiomyopathy-linked mutations disrupt the normal structure and function of the sarcomere.
Keywords: Dilated cardiomyopathy; Hypertrophic cardiomyopathy; Interacting-heads motif; Sarcomere physiology.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.
Figures


Similar articles
-
Advances in the Genetic Basis and Pathogenesis of Sarcomere Cardiomyopathies.Annu Rev Genomics Hum Genet. 2019 Aug 31;20:129-153. doi: 10.1146/annurev-genom-083118-015306. Epub 2019 Apr 12. Annu Rev Genomics Hum Genet. 2019. PMID: 30978303 Review.
-
Mechanisms of Sarcomere Protein Mutation-Induced Cardiomyopathies.Curr Cardiol Rep. 2023 Jun;25(6):473-484. doi: 10.1007/s11886-023-01876-9. Epub 2023 Apr 15. Curr Cardiol Rep. 2023. PMID: 37060436 Free PMC article. Review.
-
Genetics of hypertrophic and dilated cardiomyopathy.Curr Pharm Biotechnol. 2012 Oct;13(13):2467-76. doi: 10.2174/138920112804583041. Curr Pharm Biotechnol. 2012. PMID: 22280421 Review.
-
Subtle abnormalities in contractile function are an early manifestation of sarcomere mutations in dilated cardiomyopathy.Circ Cardiovasc Genet. 2012 Oct 1;5(5):503-10. doi: 10.1161/CIRCGENETICS.112.962761. Epub 2012 Sep 4. Circ Cardiovasc Genet. 2012. PMID: 22949430 Free PMC article.
-
Furthering the link between the sarcomere and primary cardiomyopathies: restrictive cardiomyopathy associated with multiple mutations in genes previously associated with hypertrophic or dilated cardiomyopathy.Am J Med Genet A. 2011 Sep;155A(9):2229-35. doi: 10.1002/ajmg.a.34097. Epub 2011 Aug 5. Am J Med Genet A. 2011. PMID: 21823217 Free PMC article.
Cited by
-
Prolonged cross-bridge binding triggers muscle dysfunction in a Drosophila model of myosin-based hypertrophic cardiomyopathy.Elife. 2018 Aug 13;7:e38064. doi: 10.7554/eLife.38064. Elife. 2018. PMID: 30102150 Free PMC article.
-
An Update on Pediatric Cardiomyopathy.Curr Treat Options Cardiovasc Med. 2019 Jun 25;21(8):36. doi: 10.1007/s11936-019-0739-y. Curr Treat Options Cardiovasc Med. 2019. PMID: 31236771 Review.
-
A comprehensive guide to genetic variants and post-translational modifications of cardiac troponin C.J Muscle Res Cell Motil. 2021 Jun;42(2):323-342. doi: 10.1007/s10974-020-09592-5. Epub 2020 Nov 11. J Muscle Res Cell Motil. 2021. PMID: 33179204 Free PMC article.
-
Long-term effect of mavacamten in obstructive hypertrophic cardiomyopathy.Eur Heart J. 2024 Dec 16;45(47):5071-5083. doi: 10.1093/eurheartj/ehae579. Eur Heart J. 2024. PMID: 39217450 Free PMC article.
-
Impact of the Myosin Modulator Mavacamten on Force Generation and Cross-Bridge Behavior in a Murine Model of Hypercontractility.J Am Heart Assoc. 2018 Sep 4;7(17):e009627. doi: 10.1161/JAHA.118.009627. J Am Heart Assoc. 2018. PMID: 30371160 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources